Acetylation of polyamines by spermidine/spermine N 1 -acetyltransferase (SSAT) has been implicated in their degradation and/or export out of the cell. The relationship of SSAT to polyamine pool dynamics and cell growth is not yet clearly understood. MCF-7 human breast carcinoma cells were transfected with tetracycline-regulated (Tet-off) SSAT human cDNA or murine gene. Doxycycline removal for >2 days caused a ϳ20-fold increase in SSAT RNA and a ϳ10-fold increase in enzyme activity. After 4 days, intracellular putrescine and spermidine pools were markedly lowered, and cell growth was inhibited. Growth inhibition could not be prevented with exogenous polyamines due to a previously unrecognized ability of SSAT to rapidly acetylate influxing polyamines and thereby prevent restoration of the endogenous pools. Instead, cells accumulated high levels of N 1 -acetylspermidine, N 1 -acetylspermine, and N 1 ,N 12 -diacetylspermine, a metabolite not previously reported in mammalian cells. Doxycycline deprivation before treatment with N 1 ,N
Intracellular polyamine pools appear to be sensitively regulated by various homeostatic responses that typically include effectors of polyamine biosynthesis, catabolism, and transport. Best known among these are the key enzymes involved in polyamine biosynthesis, ornithine decarboxylase (ODC) 1 and S-adenosylmethionine decarboxylase. Increases in ODC are often associated with initiation of normal cell growth and with sustained neoplastic cell growth. Overexpression of ODC activity is a well recognized feature of many cancers, and in at least one tumor type, this increase in activity has been attributed to a point mutation leading to stabilization of the typically labile enzyme protein (1) . Such findings form the rationale for certain cancer therapeutic and prevention strategies targeting polyamine metabolism. These efforts rely on inhibitors to block biosynthetic enzyme activity (2) (3) (4) (5) or, alternatively, on polyamine analogs to down-regulate enzyme activities (6, 7) . In the course of studying the cellular effects of bis-ethylated spermidine and spermine analogs, investigators (8 -10) found that in addition to down-regulating ODC and S-adenosylmethionine decarboxylase, certain analogs potently up-regulate the polyamine catabolic enzyme, spermidine/spermine N 1 -acetyltransferase (SSAT). The enzyme acetylates higher polyamines that are then either excreted out of the cell or acted upon by a flavin-adenine-dependent polyamine oxidase, leading to the back-conversion of spermine (Spm) to spermidine (Spd) and Spd to putrescine (Put) (11, 12) .
In the absence of specific SSAT inhibitors, the metabolic significance of changes in enzyme activity has not yet been clearly discerned. In fact, the role of this enzyme in modulating intracellular polyamine pools is largely inferred from its enzymatic function. Much of what is known regarding the cellular consequences of SSAT is based on studies with polyamine analogs such as N 1 ,N 11 -diethylnorspermine (DENSPM), which potently induce the enzyme (9, 10, 13, 14) . Cause and effect relationships have been difficult to establish with such analogs since, as noted above, they have other effects on polyamine metabolism and are known to exert a somewhat paradoxical inhibition of the SSAT enzyme (15) .
Our earlier studies examined SSAT function in fetal fibroblasts from transgenic animals that overexpress SSAT (16, 17) . A 10-fold increase in enzyme activity was found to correlate with lowered Spd and Spm pools and increased Put and acetylated polyamine pools. More recently, McCloskey et al. (18) stably overexpressed SSAT in Chinese hamster ovary (CHO) cells and observed similar polyamine pool perturbations. Since in both instances cell growth was not affected, we reasoned that metabolic adaptations that took place following transfection may have masked the effects of SSAT overexpression on polyamine pool dynamics and cell growth.
In this present study, we investigated the polyamine and cellular consequences of conditional SSAT expression. In particular, we derived cells transfected with either the human SSAT cDNA or the murine SSAT gene under the control of a tetracycline-regulatable (Tet-off) promoter (19) . The results demonstrate a previously unappreciated ability of SSAT to (a) regulate intracellular polyamine pools against a huge extracellular gradient, (b) diacetylate Spm, (c) negatively affect cell growth, and (d) markedly enhance growth inhibition by polyamine analogs. Cell Cultures-A MCF-7 cell line stably transfected with a Tet-off transfection system was purchased from CLONTECH Laboratories Inc. (Palo Alto, CA). The cells were cultured in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 2 mM glutamine, 10% fetal bovine serum, penicillin at 100 units/ml, streptomycin at 100 units/ml, and the antibiotic G418 (Life Technologies) at 100 g/ml at 37°C in the presence of 5% CO 2 . Cells were harvested by trypsinization and counted electronically (Coulter Model ZM, Coulter Electronics, Hialeah, FL). 1 mM aminoguanidine was routinely included in the media as an inhibitor copper-dependent bovine serum amino oxidase to prevent oxidation of extracellular polyamines to toxic products.
EXPERIMENTAL PROCEDURES

Materials-The
Cloning-An EcoRI fragment containing the complete human SSAT cDNA (21) was cloned into a pTRE expression vector (CLONTECH Laboratories) that contained a tetracycline-responsive element. Similarly, an FspI-BamHI fragment containing a major portion of the murine SSAT gene (22) lacking the 5Ј-flanking region and all except the first 28 nucleotides of the 5Ј-untranslated region of the first exon was also cloned into a pTRE expression vector (Fig. 1) .
Transfections-MCF-7 cells containing the pTet-off plasmid were transfected with the pTRE/expression plasmids described above using the Lipofectin method (23) . To facilitate clone selection, cells were co-transfected with a pTK-Hyg vector (CLONTECH Laboratories, Inc.). Transfected clones resistant to 100 g/ml hygromycin B (CLONTECH Laboratories, Inc.) were selected and tested for SSAT enzyme activity and/or mRNA in the presence or absence of 200 ng/ml doxycycline hydrochloride (Dox, Sigma-Aldrich). In the presence of Dox (ϩDox), SSAT transcription is not induced; in the absence of Dox (ϪDox), SSAT transcription is induced. A Dox concentration of 200 ng/ml was found to be the minimum antibiotic concentration required to fully and consistently suppress SSAT gene expression during cell culture passage. Clones that expressed the lowest basal levels of SSAT activity or mRNA in ϩDox and the highest induced level of SSAT activity or mRNA in ϪDox were selected for further study. Clones were maintained continuously under ϩDox conditions until experiments were initiated.
Polyamine and Polyamine Analog Pools-Intracellular polyamines including acetylated polyamines and polyamine analogs were extracted from cell pellets with 0.6 N perchloric acid, dansylated, and measured by reverse phase HPLC as described previously (24) with the following modifications. Dansylated samples (50 l) were injected onto a 250-mm x 3.2-mm internal diameter Econosil C18 column (5-m particle size, Alltech, Deerfield, IL) with a column temperature of 50°C and eluted by a two-solvent gradient using a Waters 616 LC system (Waters Corporation, Milford, MA) and a Waters WISP 710B autosampler. Solvent A contained 55% 10 mM ammonium phosphate, 45% acetonitrile at pH 4.4. Solvent B contained 100% acetonitrile. At 0.9 ml/min,
FIG. 2.
Northern blot analysis of SSAT RNA expression in various MCF-7 clones transfected with Tet-regulatable human SSAT cDNA (MCF-7/hSc cells). The cells were cultured for 48 h in the presence (ϩ) or absence (Ϫ) of 200 ng/ml Dox. Note that the 1.3-kb endogenous (endo) and ϳ1.5-kb exogenous (exo, i.e. plasmid transcript) mature SSAT mRNA can be distinguished on the basis of size and that overexpression of SSAT cDNA was accompanied by the accumulation of what is presumed to be preprocessed or heteronuclear (hnRNA, ϳ3.5 kb) SSAT RNA (25) . Fold 1 refers to the increase in mature mRNA in each clone incubated in ϪDox relative to the amount found in ϩDox. Blots are representative of findings from two separate experiments using 30 g of total RNA/lane. Loading differences were adjusted with glyceraldehyde-3Ј-phosphate dehydrogenase (GAPDH).
FIG. 1.
Constructs used for transfection of Tet-regulatable human SSAT cDNA and murine SSAT genomic sequences into MCF-7 cells. An EcoRI fragment containing the complete human SSAT cDNA was cloned into an expression vector containing a tetracycline-responsive element (TRE). Similarly, a fragment containing a major portion of the murine SSAT gene minus the 5Ј-flanking region and all but the first 28 nucleotides of the 5Ј-untranslated region (5ЈUTR) of the first exon was cloned into the same expression vector. nt, nucleotides; P(minCMV), minimal CMV promoter.
the gradient began at 100% solvent A and progressed linearly to 82% solvent B over 30 min with a 15-min hold. Compounds were detected using a McPherson FL-750 BX fluorescence detector (McPherson, Acton, MA) with an excitation wavelength of 360 nm and an emission cut-off filter of 500 nm. The data were collected and analyzed using Millennium 32 chromatography software (version 3.05).
Analytical Methods-Total RNA was extracted with guanidine isothiocyanate and purified by cesium chloride gradient centrifugation. Human SSAT cDNA probe (21) was used in Northern blot analyses. ODC and SSAT enzyme activities were assayed as reported earlier (14) .
RESULTS
Derivation and Selection of Transfectants-Cells transfected with either the human SSAT cDNA (MCF-7/hSc) or the murine SSAT gene (MCF-7/mSg) were selected in hygromycin and grown as clones in the presence of Dox. Of 11 MCF-7/hSc clones ( Fig. 2) , those most sensitive to Dox regulation were selected according to the differential between SSAT mRNA in the presence of Dox (ϩDox, SSAT-uninduced) versus mRNA in the absence of Dox (ϪDox, SSAT-induced). Clone H-12, which was ideal in this regard, was lost in passaging. Subsequent attention focused on clone H-10, which displayed a 20 -30-fold increase in SSAT mRNA (Figs. 2 and 3) after Dox removal for 48 h. The SSAT mRNA from the transfected human cDNA (ϳ1.5 kb) was clearly distinguishable from the smaller (ϳ1.3 kb) endogenous transcript, presumably because of differences in polyadenylation, which we have previously shown to be affected by enzyme induction (25) . Notice that although the exogenous 1.5-kb transcript levels increased with Dox removal, the endogenous 1.3-kb transcript levels remained the same. One unexpected finding was the appearance of two bands in the region of ϳ3.5-kb SSAT RNA that previous studies (25) have shown to be heteronuclear (hnRNA) in origin. Since these could not have originated from the cDNA, we can only speculate that induced SSAT gene expression may in some way interfere with processing of the endogenous heteronuclear RNA, but this remains to be investigated.
The same selection strategy, applied to MCF-7 cells transfected with the murine SSAT gene (MCF-7/mSg cells), led to the identification of the M-3 clone (shown in Fig. 8 ). The M-3 clone showed a ϳ3-fold increase in SSAT mRNA after Dox removal for 48 h. As expected for transfected genomic sequences, this SSAT mRNA was apparent as a mature ϳ1.3-kb species comparable in size with the endogenous message and as a less abundant preprocessed ϳ3.5-kb RNA.
The time dependence of Dox-regulated expression of SSAT mRNA and activity was characterized in the newly selected H-10 clone (Fig. 3) . After Dox removal, SSAT mRNA increased most rapidly during the first 6 h, after which it reached a plateau that typically ranged between 19-and 34-fold. This induction of mRNA was accompanied by a more modest rise in SSAT activity, which reached a maximum of ϳ10-fold range (see Fig. 3 and Table I ). In the case of M-3 cells, a more modest 3-fold increase in mRNA led to an increase in SSAT activity similar to that seen in H-10 cells (Table I) .
Effects of SSAT Overexpression on Polyamine MetabolismThe time-dependent metabolic consequences of SSAT overexpression on polyamine metabolism were evaluated in the H-10 clone (Table I) . Interestingly, there did not appear to be a compensatory rise in ODC activity as has been seen in systems bearing stably transfected SSAT (16 -18) . The typical ϳ10-fold increase in SSAT activity was seen to have an obvious effect on polyamine pools. After 48-h of Dox, Put pools were lowered by ϳ45% relative to zero time, Spd pools were lowered by ϳ54%, and Spm was not significantly affected. At 96 h, Spd pools were further decreased to Ͻ30% zero control, indicating the progressive effect of SSAT overexpression. Consistent with SSAT enzymatic function, acetylated polyamine pools were profoundly increased. N 1 -Acetyl-Spd increased from Ͻ5 to 1750 and 2285 pmol/10 6 cells by 48 and 96 h, respectively. The other enzyme product N 1 -acetyl-Spm, which is rarely seen in cells, increased from Ͻ5 pmol/10 6 cells in ϩDox cells to 165 pmol/10 6 cells in ϪDox cells at 96 h. We also noted significant amounts of a novel polyamine peak that was subsequently identified as N 
Conditional Overexpression of SSAT in MCF-7 Cells
Very similar trends were observed in M-3 cells transfected with murine SSAT genomic sequences (MCF-7/mSg cells, Table  I ). As with the H-10 cells, Put and Spd pools decreased with the former, falling to 36% of the zero control, and the latter, to 25% of control by 96 h. In previous studies with SSAT transgenic mice (16) and in the embryo fibroblasts derived from them (17), Put pools increased rather than decreased. This may be because ODC activity increased in the stably transfected systems but remained relatively constant during conditional overexpression of SSAT (Table I) .
Effects of SSAT Expression on Cell Growth- Fig. 4 shows that conditional overexpression of SSAT causes a sustained reduction in growth in both H-10 or M-3 cells after Dox removal. M-3 cells were more sensitive than H-10 cells even though Spd pools were similarly depleted in both clones (Table  I) . In both cases, the growth response appeared to be cytostatic rather than cytotoxic in nature, since cell proliferation continued albeit at a reduced rate. Table I and Fig. 4 indicate that SSAT overexpression and the attendant inhibition of cell growth may be directly related to a reduction in intracellular Spd pools. Because Spd is generally regarded as the polyamine most critically required for cell growth (3), we investigated whether it could prevent growth inhibition. This strategy is typically employed to validate the specificity of polyamine enzyme inhibitors (2, 3). For these studies, H-10 cells were continuously exposed (or not exposed) to 10 M Spd after Dox removal. As shown in Fig. 5 , 10 M Spd failed to prevent growth inhibition associated with SSAT induction. Although this would suggest that Spd depletion is not responsible for growth inhibition, polyamine pool analysis (Table II) revealed that intracellular Spd pools in ϪDox cells were not restored by this treatment. Rather, N 1 -acetyl-Spd accumulated to enormous levels (5660 pmol/10 6 cells), whereas Spd pools remained at Ͻ50% that seen in ϩDox cell levels, apparently because overexpressed SSAT rapidly converts influxing Spd to the acetylated derivative. Thus, the data do not exclude the possibility that growth inhibition is due to Spd depletion.
Effects of Exogenous Polyamines on SSAT Induced Growth Inhibition and Pool Dynamics-The data in
These findings prompted us to examine whether higher concentrations of Spd might be able to saturate SSAT and allow for restoration of Spd pools and prevention of growth inhibition. Here, we encountered the unexpected finding that external Spd concentrations as high as 500 M were still unable to restore intracellular Spd pools (Fig. 6) or to prevent growth inhibition (Table III and Fig. 6 legend) . Although cells grown ϩDox and treated with increasing levels of exogenous Spd clearly accumulated higher than normal Spd levels (up to 150%), cells grown ϪDox did not. Intracellular Spd pools remained at subnormal levels, whereas N 1 -acetyl-Spd rose to extremely high levels, increasing from Ͻ5 to Ͼ14,000 pmol/10 6 cells during treatment with 500 M Spd. Thus, even unusually high levels of exogenous Spd were unable to restore intracellular Spd pools and prevent growth inhibition in SSAT-induced cells.
A detailed analysis of HPLC chromatograms (Fig. 7 ) fromϪDox cells treated with Spd revealed an additional peak that eluted before N 1 -acetyl-Spd and rose significantly with exposure to increasing concentrations of Spd (Fig. 6) . Spiking cellular extracts with authentic N 1 ,N 12 -diacetyl-Spm confirmed a retention time coincident with the unknown peak (Fig.  7) . The identity of the peak was further indicated by the finding (data not shown) that it increased remarkably in cells treated with 10 M N 1 -acetyl-Spm, presumably because the latter was rapidly converted to N (Table III, Fig. 6 ). Given the ability of overexpressed SSAT to prevent restoration of Spd pools, we investigated the possibility that either exogenous Put, which is not acetylated by SSAT, or exogenous Spm, which can be back-converted to Spd, might prevent growth inhibition by being metabolized to Spd. As with Spd, a full concentration range of 20, 100, and 500 M was tested for both polyamines; however, only the 100 M data are shown in Table III Finally, we examined whether the limitation in Spd accumulation could be overcome by pretreatment with the ODC inhibitor ␣-difluoromethylornithine (DFMO). Inhibition of polyamine biosynthesis elicits various compensatory responses including a very significant increase in polyamine uptake (26) , and we reasoned that this response might abrogate the ability of SSAT to prevent intracellular Spd accumulation. As shown in Table III , even this manipulation was incapable of overriding the ability of induced SSAT to limit intracellular Spd accumulation.
DENSPM and Spm Induction of SSAT mRNA, SSAT Activity, and Polyamine Pools-We next examined the relative effects of conditional SSAT overexpression on various cellular responses to DENSPM. Fig. 8 shows the SSAT mRNA levels in H-10 and M-3 cells grown ϮDox for 48 h and then treated with 10 M DENSPM or 10 M Spm for an additional 24 h. In clone H-10, steady-state levels of SSAT message were ϳ20-fold higher in ϪDox cells than in ϩDox cells. When exposed to 10 M DENSPM for 24 h, mRNA levels increased 4-fold in ϩDox cells, whereas that in ϪDox cells remained unchanged at ϳ20-fold. Presumably, some rate-limiting step prevented DENSPM from increasing mRNA beyond the already high levels in these cells. Data in Fig. 8 also show that relative to DENSPM, the natural polyamine Spm produced much more modest increases in SSAT mRNA. This was more apparent in M-3 cells than in H-10 cells. The 4-fold and 20-fold difference in mRNA levels seen in DENSPM-treated ϩDox and ϪDox cells (Fig. 8) resulted in a ϳ180-fold and ϳ3500-fold increase (relative to 0 h ϩDox), respectively, in SSAT activity in H-10 cells (Fig. 9) . A similar differential in SSAT was observed in the DENSPMtreated M-3 cells. As is known from other systems (16, 17) , DENSPM also suppressed ODC activity in M-3 and H-10 cells irrespective of prior SSAT induction with Dox (data not shown). Similarly, the analog produced a near total depletion of all three polyamines by 48 h.
Relative Growth Inhibition by DENSPM-The relative antiproliferative effect exerted by DENSPM in H-10 and M-3 cells grown ϮDox was studied over an extended (8 day) time period. As shown in the Fig. 10 , H-10 ϪDox cells were strikingly more sensitive to the antiproliferative action of the DENSPM than ϩDox cells. Less than 15% growth inhibition was achieved by 48 h in ϩDox H-10 cells compared with Ͼ80% in ϪDox cells (Fig. 10) . A similar difference in response to DENSPM was The upper band in the autoradiogram represents heterogeneous nuclear RNA (hnRNA), and the lower band is mature SSAT mRNA. For quantitation, SSAT mRNA bands were scanned densitometrically on differentially exposed autoradiograms, normalized to glyceraldehyde-3Ј-phosphate dehydrogenase (GAPDH), and expressed as fold increase of treated versus untreated samples. For clone H-10, the endogenous (endo) and exogenous (exo) mRNA bands were combined in calculating fold increase. Blots are representative of findings from two separate experiments using 30 g of total RNA/lane. Con, control.
observed in M-3 cells, where growth was much more in ϪDox-induced cells than in ϩDox cells. As a generality, DENSPMmediated growth inhibition was more cytotoxic during SSAT induction, as indicated by the more rapid and complete loss in cell number (Fig. 10) . It is also noteworthy that cellular levels of DENSPM were very similar in induced and uninduced cells (i.e. 6445 versus 5820 at pmol/10 6 cells at 2 days in H-10 cells), indicating that differences in analog accumulation could not account for either the differential induction of SSAT or the inhibition of cell growth.
The increased sensitivity of SSAT-induced H-10 cells to DENSPM was quantitated by dose-response analysis. As shown in Fig. 11 , cells were grown for 2 days ϮDox and then exposed to increasing concentrations of DENSPM for 2 days. In the IC 50 comparisons, ϪDox cells were ϳ100-fold more sensitive to DENSPM than ϩDox cells (i.e. comparing IC 50 values of 0.2 and 20 M, respectively). Taken together, the data in Figs. 10 and 11 indicate that the onset of cytotoxicity occurs more rapidly and at lower DENSPM concentrations in cells that overexpress SSAT.
DISCUSSION
Polyamine analogs such as DENSPM are known to suppress the polyamine biosynthetic activities, down-regulate polyamine uptake, and potently induce the polyamine catabolic enzyme SSAT. The magnitude and rapidity of this SSAT response has prompted interest in its potential for mediating polyamine pool depletion and cell growth inhibition. These investigations, however, have been complicated by the pleiotropic nature of analog effects on polyamine metabolism and perhaps other pathways. Thus, previous studies examining the relationship of SSAT induction to changes in polyamine metabolism and cell growth have been based on the use of (a) analogs having different abilities to induce SSAT (13, 14, 28), (b) paired cells lines that differentially induced SSAT in response to the same analog (10, 14, 28, 29) , (c) fibroblasts from nontransgenic and transgenic animals that systemically overexpress SSAT (17), or (d) very recently, CHO cells, which overexpress SSAT via stable transfection (18) . All four approaches have inherent interpretative limitations. Analogs, which differ in their ability to induce SSAT, might also differ in effects at other polyaminerelated or unrelated sites. Similarly, cell lines derived from various human tumors and patients obviously differ in more ways than their ability to induce SSAT. Finally, both murine fibroblasts from transgenic animals overexpressing SSAT (17) and transfected cell lines (18) are likely to have undergone metabolic adaptations during embryogenesis and clonal selection, respectively. These in turn could compensate for increased levels of SSAT expression and thus mask various metabolic and cellular responses to gene overexpression. In the present study, we have derived cells that conditionally overexpress SSAT on relatively short notice to the cell. This evaluation of the metabolic and cellular consequences of enzyme induction within the same cells has provided several unexpected findings.
One of the more important findings revealed in the present study is that conditional induction of SSAT activity is sufficient to both lower polyamine pools and inhibit cell growth. The finding differs from our previous characterization of polyamine biosynthesis in fibroblasts from nontransgenic and transgenic animals that systemically overexpressed SSAT activity by ϳ20-fold (16) . Although polyamine pools of the SSAT transgenic fibroblasts were much lower than nontransgenic fibroblasts, their growth rate was nearly identical (17) . Similar growth rates were also reported in parental and SSAT-transfected CHO cells (18) . We believe that this apparent lack of SSAT effect on cell growth is related to compensatory metabolic adjustments in the fibroblasts and CHO cells. As one example, we note that the basal ODC activity was increased 20-fold in SSAT transgenic livers (16), 3-fold in transgenic fibroblasts (17) , and 4 -5-fold in SSAT-transfected CHO cells (18) . Such metabolic adjustments could compensate for SSAT-induced increases in polyamine catabolism and excretion by increasing polyamine biosynthetic activity; other unknown genes could be similarly affected. Under the conditional expression system used here, removal of Dox for 48 h resulted in a ϳ10-fold increase in SSAT activity in the absence of increases in ODC activity. Thus, this lack of an ODC response during rapid onset SSAT overexpression could account for the growth inhibition seen in the MCF-7 cells transfected with either the SSAT murine genomic sequences or human cDNA. Taken together, the data indicate that spontaneous and specific induction of SSAT can negatively affect cell growth.
The inhibition of cell growth brought about by conditional overexpression of SSAT correlates with a progressive reduction in polyamine pools. Although shifts in polyamine pool profiles are seen in cells stably transfected with SSAT, these changes reflect steady-state conditions that do not progress with time. The ϳ10-fold increase in SSAT activity in ϪDox-induced H-10 cells results in a rapid and progressive depletion of the Spd pool; Put and Spm pools are much less affected. Spd depletion is accompanied by a massive accumulation of acetylated Spd and Spm products that are either degraded via the polyamine oxidase pathway or excreted out of the cell (13, 14) . Although the rate of polyamine pool decline is not as rapid or as complete as that seen with polyamine analog treatment, it should be recalled that in addition to inducing SSAT activity to much higher levels, the analogs also rapidly down-regulate ODC and S-adenosylmethionine decarboxylase (14) . Thus, it is not unexpected that growth inhibition by selective SSAT induction is slower to develop and less cytotoxic than that produced by DENSPM (10, 14, 27, 28) . Rather, the more cytostatic response seen with conditional SSAT induction resembles growth inhibition seen during polyamine depletion achieved with specific enzyme inhibitors (2, 3) .
To examine the relationship of polyamine depletion and growth inhibition, we attempted to prevent the latter with the exogenous Spd, a strategy commonly used in demonstrating specificity with polyamine inhibitors (2, 3) . As shown in Fig. 5 and Table III , 10 M Spd failed to prevent inhibition. Intracellular pool analysis indicated, however, that despite increasing intracellular Spd pools in uninduced cells, exogenous Spd was unable to replenish those of SSAT-induced (ϪDox) cells. Instead, the polyamine was rapidly converted to N 1 -acetyl-Spd and apparently rendered incapable of contributing to cell growth. Attempts to overcome this with higher concentrations of Spd revealed an extraordinary ability of this enzyme to control pool dynamics. Despite extracellular Spd concentrations up to 500 M, intracellular polyamine pools including those of Put and Spm remained lower than those in uninduced cells. By contrast, the pools of N 1 -acetyl-Spd and a newly recognized mammalian cell metabolite, N 1 ,N 12 -diacetyl-Spm, rose dramatically. It is interesting that these acetylated polyamines failed to appear in uninduced cells even when the latter were treated with high levels of Spd. The massive accumulation of acetylated polyamines apparently overwhelms the ability of the cell to either oxidize or export them. The findings reveal a previously unappreciated ability for SSAT to control intracellular polyamine pools even under conditions of a non-physiological polyamine challenge. Furthermore, this ability could not be compromised by DFMO treatment, a perturbation that typically favors Spd accumulation due to its well known ability to enhance polyamine uptake (26) . This particular finding could have significance in the development of SSAT induction strategies to circumvent the ability of tumor cells to escape the antitumor activity of polyamine inhibitors such as DFMO by salvaging exogenous polyamines (30) .
Due to the ability of SSAT to resist Spd pool restoration, we could not definitively demonstrate whether Spd pool depletion is responsible for SSAT-induced growth inhibition. An alternative cause of growth inhibition could be that high levels of acetylated polyamines may exert a toxic effect. Although acetylated polyamines were markedly increased in SSAT-overexpressing cells, they have never been convincingly linked to growth inhibition. Furthermore, we observed that markedly increasing their intracellular levels during treatment with 20, 100, or 500 M Spd (Fig. 7) or Spm (Table III) neither increased nor decreased growth inhibition. Although this reasoning also discounts the possibility that the toxic products liberated via oxidation of acetylated polyamines is responsible for SSATinduced growth inhibition (31), the role of polyamine oxidase in this regard warrants further investigation.
As noted above, another unexpected finding during these studies was the appearance of a new intracellular metabolite, identified as N 1 ,N 12 -diacetyl-Spm. Apparently the SSAT enzyme is capable of recognizing the remaining aminopropyl moiety of N 1 -acetyl-Spm and acetylates it, giving rise to the diacetylated metabolite. It is interesting and somewhat unexpected that N 1 ,N 12 -diacetyl-Spm increases with exogenous Spd concentrations, whereas N 1 -acetyl-Spm remains relatively constant (Fig. 6) . Similarly, it was also noted that Spm treatment of induced cells increased N 1 ,N 12 -diacetyl-Spm pools by Ͼ5 times more than N 1 -acetyl-Spm pools (i.e. 4830 versus 895 pmol/10 6 cells, respectively). This selective accumulation of the diacetylated product over the monoacetylated product could be due to (a) direct diacetylation without release of the monoacetylated product, (b) the preferred use of N 1 -acetyl-Spm as a substrate for additional acetylation, (c) the fact that the polyamine oxidase enzyme has a higher affinity for N 1 -acetyl-Spm -diacetyl-Spm has been recognized as a potential SSAT product in acellular systems (32, 33) , it has to our knowledge not been previously identified in mammalian tissues or cell cultures. It has, however, been described in urine from rats treated with a polyamine oxidase inhibitor (34) and in normal human urine (35) . As a consequence of these present findings, we undertook a retrospective analysis of chromatograms from DENSPM-treated MALME-3M human melanoma cells, which induced huge amounts of SSAT (14) . This effort revealed the previously unnoticed presence of a significant N 1 ,N 12 -diacetyl-Spm peak that was confirmed by spiking experiments (data not shown). Thus, the generation of this novel metabolite during various pharmacological perturbations may be more widespread than previously appreciated, and it could have usefulness as a clinical marker in ongoing clinical trials with analogs that induce SSAT.
As shown in Fig. 12 , an important implication of the findings with exogenous Spd is that once N 1 -acetyl-Spm is converted to N 1 ,N 12 -diacetyl-Spm, the metabolite loses its potential to be oxidized directly back to Spd. For example, N 1 -acetyl-Spm can be back-converted to Spd by polyamine oxidase, whereas N 1 ,N 12 -diacetyl-Spm would be back-converted by polyamine oxidase to N 1 -acetyl-Spd, which could then be further oxidized to Put by-passing Spd. Thus, the rapid diacetylation of Spm in cells exposed to Spd serves to metabolically sequester excess Spm and, at the same time, to circumvent back-conversion to Spd. If as dogma indicates, acetylation of polyamines by SSAT takes place in the cytoplasm and oxidation of acetylated polyamines in another compartment such as the peroxisome (36) , then diacetylation may further facilitate the direct conversion of Spm to Put by eliminating the need to enter, leave, and re-enter the peroxisome as would be the case for N 1 -acetyl-Spm and N 1 -acetyl-Spd. Finally, we investigated the effect of conditional SSAT overexpression on DENSPM-mediated metabolic and cellular responses. SSAT induction and growth inhibition were both markedly enhanced in cells overexpressing SSAT. DENSPM increased SSAT activity by ϳ180-fold in ϩDox and by ϳ3500-fold during ϪDox induction of H-10 cells (Fig. 9) . This ϳ20-fold difference in enzyme induction correlates well with the ϳ20-fold increase in SSAT mRNA induced by Dox removal. Amplification of the RNA induction is due to the ability of DENSPM to invoke various post-transcriptional regulatory events involving SSAT mRNA stabilization (25) , translation (37) (38) (39) (40) (41) , and protein stabilization (9, 28, 42, 43) . The DENSPM dose-response curves (Fig. 11) give a quantitative indication of the extent to which analog induction of SSAT is related to growth inhibition. More particularly, a 20-fold difference in basal SSAT mRNA levels converts into a 100-fold increase in growth sensitivity to the analog. Together with data obtained with SSAT transgenic fibroblasts (17) , the present findings establish a direct relationship between analog induction of SSAT and inhibition of cell growth. In further support of this conclusion, McCloskey and Pegg (44) recently report that DENSPM-resistant CHO cells induce much less SSAT than parental cells due to a mutation in the coding region of the SSAT protein.
Overall, the potential for SSAT induction to mediate growth inhibition and to enhance sensitivity to DENSPM has been clearly demonstrated for the first time. This latter finding suggests that activation of polyamine catabolism may represent an alternative strategy to the use of biosynthetic inhibitors as a means to achieve polyamine depletion and growth inhibition. Thus, it may be useful to search for new classes of compounds capable of potently inducing SSAT and having favorable pharmacological properties in animals as potential anticancer agents. Table III , Figs. 6 and 7) . As shown in the illustration, this metabolite bypasses back-conversion to Spd going directly to N 1 -acetyl-Spd, which in turn is oxidized to Put. Evidence for oxidation of N 1 ,N 12 -diacetyl-Spm by polyamine oxidase is presented in Table III , where it is shown that inhibition of polyamine oxidase by MDL-72527 leads to a decrease in N 1 -acetyl-Spd and a huge accumulation of N 1 ,N 12 -diacetyl-Spm in ϪDox H-10 cells.
